论文部分内容阅读
作者认为对奴卡氏放线菌感染至今尚无理想的治疗方法。为了估价甲氧苄氨嘧啶-磺胺甲基异(哑心)唑(TMP-SMZ)的疗效,他们在Duke大学医学中心调查了19例放线菌感染的病人病史。19例病人中除5例是
The authors believe there is no ideal treatment for Actinobacillus niacin infection so far. To assess the efficacy of trimethoprim-sulfamethoxazole (TMP-SMZ), they investigated the history of 19 patients with actinomycetes infection at the Duke University Medical Center. Of the 19 patients, 5 were excluded